Breaking News Instant updates and real-time market news.

DGX

Quest Diagnostics

$102.11

0.56 (0.55%)

11:06
09/23/17
09/23
11:06
09/23/17
11:06

Quest Diagnostics 'disappointed' with proposed PAMA 2018 Medicare payment rates

Quest Diagnostics has responded to the Centers for Medicare and Medicaid Services, or CMS, publication of proposed 2018 Medicare reimbursement rates for clinical laboratory tests under the Clinical Lab Fee Schedule, or CLFS, pursuant to Protecting Access to Medicare Act, or PAMA, announced September 22, 2017. "We are deeply disappointed that CMS has issued draft 2018 Medicare payment rates that are not market-based and derived from flawed market data collection that excluded key components of the lab market," said Steve Rusckowski, Chairman, President and CEO of Quest Diagnostics. "For example, hospitals and physician office labs comprise half of Medicare CLFS volume and lab spending, but only accounted for 8.5% of the reported lab volume used by CMS to calculate the rates. These draft rates are counter to the intent of Congress and will likely cause significant negative impacts to Medicare beneficiary access to lab services. These rates should not be finalized, and I fully support the American Clinical Laboratory Association's plan to explore all available options, including the courts if necessary, to ensure that patients have access to the services we provide."

  • 30

    Nov

DGX Quest Diagnostics
$102.11

0.56 (0.55%)

09/18/17
CHLM
09/18/17
NO CHANGE
CHLM
Quest, LabCorp better prepared to absorb PAMA impact, says Craig-Hallum
Craig-Hallum analyst Kevin Ellich believes the large independent labs, Quest Diagnostics (DGX) and LabCorp (LH), are better prepared to absorb the potential impact from PAMA - Protecting Access to Medicare Act - if it is implemented, as slated, on January 1, 2018 than smaller labs. The analyst does not believe PAMA is fully reflected in the valuations of the stocks, and thinks Quest Diagnostics and LabCorp could benefit from increased testing volume as potential rate cuts attributable to PAMA could push smaller labs out of business while pressuring hospital lab margins such that hospitals might choose to rationalize their lab businesses.
09/11/17
ADAM
09/11/17
NO CHANGE
Target $180
ADAM
Buy
LabCorp price target raised to $180, remains top pick for 2017, says Canaccord
Canaccord analyst Mark Massaro raised his price target on LabCorp (LH) to $180 from $175 and said it remains one of his top five picks for 2017. Massaro said the stock's valuation remains below competitor Quest Diagnostics (DGX) and he believes investors should own shares in both companies. He noted LabCorp completed its acquisition of Chiltern, which he estimates can be accretive to earnings in year one. Massaro reiterated his Buy rating on LabCorp. shares.
07/26/17
ADAM
07/26/17
NO CHANGE
Target $118
ADAM
Buy
Quest Diagnostics weakness overdone, says Canaccord
Canaccord analyst Mark Massaro said Quest Diagnostics delivered solid Q2 results and raised its guidance. He believes Quest is well positioned to achieve growth from acquisitions, develop higher fee cash flow, and continue stock buybacks. Massaro said yesterday's modest pullback is overdone and he reiterated his Buy rating and $118 price target on Quest Diagnostics shares.
07/25/17
BOFA
07/25/17
UPGRADE
Target $118
BOFA
Buy
Quest Diagnostics upgraded on view FY18 consensus too low at BofA/Merrill
As previously reported, BofA/Merrill Lynch analyst Steven Valiquette upgraded Quest Diagnostics to Buy from Neutral as he believes that consensus estimates for 2018 seem too low given Quest's current momentum and the company's increased FY17 sales and EPS guidance. Valiquette raised his 2018 EPS estimate to $6.08, which he noted is "well above" the current consensus view of $5.91, adding that a delay in PAMA reimbursement changes could yield further EPS upside. The analyst increased his price target on Quest shares to $118 from $111.

TODAY'S FREE FLY STORIES

BYD

Boyd Gaming

$35.02

-2.58 (-6.86%)

12:20
02/21/18
02/21
12:20
02/21/18
12:20
Options
Bullish ratio spread opened in Boyd Gaming as shares fall on earnings »

Bullish ratio spread…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

QCOM

Qualcomm

$63.99

-0.86 (-1.33%)

, AVGO

Broadcom

$249.62

0.73 (0.29%)

12:19
02/21/18
02/21
12:19
02/21/18
12:19
General news
On The Fly: Top stock stories at midday »

Stocks began the session…

QCOM

Qualcomm

$63.99

-0.86 (-1.33%)

AVGO

Broadcom

$249.62

0.73 (0.29%)

NXPI

NXP Semiconductors

$125.56

7.06 (5.96%)

FINL

Finish Line

$9.54

-0.61 (-6.01%)

QUAD

Quad/Graphics

$27.73

5.68 (25.76%)

AAP

Advance Auto Parts

$117.29

11.94 (11.33%)

INOV

Inovalon

LPSN

LivePerson

$13.10

0.65 (5.22%)

TTS

Tile Shop

SLCA

U.S. Silica

$25.93

-4.82 (-15.67%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 21

    Feb

  • 21

    Feb

  • 21

    Feb

  • 21

    Feb

  • 26

    Feb

  • 26

    Feb

  • 06

    Mar

  • 11

    Mar

  • 22

    Mar

  • 23

    Mar

  • 27

    Mar

  • 28

    Mar

  • 23

    May

  • 30

    May

$NSD

NASDAQ Market Internals

12:17
02/21/18
02/21
12:17
02/21/18
12:17
Technical Analysis
NASDAQ market internals summary »

Volume is average for…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

$NYE

NYSE Market Internals

12:16
02/21/18
02/21
12:16
02/21/18
12:16
Technical Analysis
NYSE market internals summary »

Volume is average for…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

CPB

Campbell Soup

$44.73

-1.35 (-2.93%)

12:15
02/21/18
02/21
12:15
02/21/18
12:15
Options
Campbell Soup put volume heavy and directionally bearish »

Bearish flow noted in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 21

    Feb

  • 23

    Apr

  • 30

    May

12:15
02/21/18
02/21
12:15
02/21/18
12:15
General news
FX Action: USD-JPY »

FX Action: USD-JPY has…

IBKC

Iberiabank

$83.10

-1.2 (-1.42%)

12:09
02/21/18
02/21
12:09
02/21/18
12:09
Hot Stocks
Federal Reserve approves Iberiabank purchase of Gibraltar Private Bank »

The Federal Reserve Board…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

ZN

Zion Oil & Gas

$4.47

0.43 (10.64%)

12:09
02/21/18
02/21
12:09
02/21/18
12:09
Periodicals
Zion Oil & Gas shares deserve 'to crater,' TheStreetSweeper says 

Reference Link

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

LGF.B

Lionsgate

$27.16

-0.12 (-0.44%)

, LGF.A

Lionsgate

$28.48

-0.13 (-0.45%)

12:07
02/21/18
02/21
12:07
02/21/18
12:07
Hot Stocks
Lionsgate slides as analyst cuts rating on competitive, cost concerns »

Bernstein analyst Todd…

LGF.B

Lionsgate

$27.16

-0.12 (-0.44%)

LGF.A

Lionsgate

$28.48

-0.13 (-0.45%)

DIS

Disney

$106.29

0.31 (0.29%)

FOX

21st Century Fox

$36.61

-0.43 (-1.16%)

FOXA

21st Century Fox

$37.13

-0.33 (-0.88%)

CMCSA

Comcast

$39.47

-0.32 (-0.80%)

CMCSK

Comcast

T

AT&T

$36.82

0.047 (0.13%)

TWX

Time Warner

$95.48

0.405 (0.43%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Feb

  • 26

    Feb

  • 26

    Feb

  • 27

    Feb

  • 28

    Feb

  • 01

    Mar

  • 01

    Mar

  • 05

    Mar

  • 06

    Mar

  • 20

    Mar

  • 23

    Apr

ATVI

Activision Blizzard

$70.84

0.65 (0.93%)

12:05
02/21/18
02/21
12:05
02/21/18
12:05
Periodicals
Activision's Sledgehammer founders leave studio, Kotaku reports »

Michael Condrey and Glen…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Feb

  • 26

    Feb

UNP

Union Pacific

$133.54

3.31 (2.54%)

12:05
02/21/18
02/21
12:05
02/21/18
12:05
Hot Stocks
Union Pacific backs Q1 and FY18 volume goal of slightly positive »

Comments were made…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 21

    Feb

TXN

Texas Instruments

$105.29

0.82 (0.78%)

12:01
02/21/18
02/21
12:01
02/21/18
12:01
Conference/Events
Texas Instruments management to meet with SunTrust »

Meeting to be held in the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 21

    Feb

  • 26

    Feb

  • 30

    May

BHGE

Baker Hughes

$27.48

1.04 (3.93%)

12:00
02/21/18
02/21
12:00
02/21/18
12:00
Options
Baker Hughes calls active as shares rally »

Baker Hughes calls active…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 26

    Feb

  • 27

    Feb

  • 28

    Feb

12:00
02/21/18
02/21
12:00
02/21/18
12:00
General news
FOMC minutes preview: »

FOMC minutes preview: the…

CPB

Campbell Soup

$45.10

-0.985 (-2.14%)

, LNCE

Snyder's-Lance

$50.00

0.05 (0.10%)

11:55
02/21/18
02/21
11:55
02/21/18
11:55
Hot Stocks
Campbell expects $170M in cost synergies from Snyder's-Lance deal by FY22 »

CFO Anthony DiSilvestro…

CPB

Campbell Soup

$45.10

-0.985 (-2.14%)

LNCE

Snyder's-Lance

$50.00

0.05 (0.10%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 21

    Feb

  • 23

    Apr

  • 30

    May

HBAN

Huntington Bancshares

$15.90

0.07 (0.44%)

11:50
02/21/18
02/21
11:50
02/21/18
11:50
Options
Call buyers in Huntington Bancshares »

Call buyers in Huntington…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 06

    Mar

11:50
02/21/18
02/21
11:50
02/21/18
11:50
General news
Treasury $15 B 2-year FRN reopening was weak »

Treasury $15 B 2-year FRN…

C

Citi

$77.50

1.0399 (1.36%)

11:47
02/21/18
02/21
11:47
02/21/18
11:47
Periodicals
Citi creates new position to supervise EMEA commodities banking, FT says »

According to the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Feb

  • 06

    Mar

  • 07

    Mar

  • 30

    May

XLI

Industrial Select Sector SPDR

$77.42

0.905 (1.18%)

, XLF

Financial Select Sector

$29.21

0.32 (1.11%)

11:43
02/21/18
02/21
11:43
02/21/18
11:43
Technical Analysis
Technical Take: S&P 500 hits session highs at midday »

At time of writing the…

XLI

Industrial Select Sector SPDR

$77.42

0.905 (1.18%)

XLF

Financial Select Sector

$29.21

0.32 (1.11%)

XLB

S&P Select Materials SPDR

$60.73

0.52 (0.86%)

XLK

Technology Select Sector SPDR

$67.79

0.55 (0.82%)

XLRE

Real Estate SPDR

$30.23

-0.145 (-0.48%)

XLP

Consumer Staples Sector SPDR

$54.16

-0.18 (-0.33%)

SPY

SPDR S&P 500 ETF Trust

$273.35

1.945 (0.72%)

SPX

S&P 500

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

PFE

Pfizer

$36.31

0.3 (0.83%)

, BIIB

Biogen

$287.45

-4.42 (-1.51%)

11:43
02/21/18
02/21
11:43
02/21/18
11:43
Periodicals
Breaking Periodicals news story on Pfizer, Biogen, Roche »

Pfizer loses IPR…

PFE

Pfizer

$36.31

0.3 (0.83%)

BIIB

Biogen

$287.45

-4.42 (-1.51%)

RHHBY

Roche

$29.77

-0.53 (-1.75%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Feb

  • 08

    Mar

  • 08

    Mar

  • 04

    Apr

  • 30

    May

SLCA

U.S. Silica

$26.56

-4.195 (-13.64%)

11:40
02/21/18
02/21
11:40
02/21/18
11:40
Options
Buy the dip call activity in Silica Holdings as shares tumble on earnings »

Buy the dip call activity…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 21

    Feb

  • 30

    May

CPB

Campbell Soup

$45.44

-0.64 (-1.39%)

, LNCE

Snyder's-Lance

$50.00

0.05 (0.10%)

11:36
02/21/18
02/21
11:36
02/21/18
11:36
Hot Stocks
Campbell expects Snyder's-Lance deal to deliver 'significant' cost synergies »

Says Snyder's-Lance…

CPB

Campbell Soup

$45.44

-0.64 (-1.39%)

LNCE

Snyder's-Lance

$50.00

0.05 (0.10%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 21

    Feb

  • 23

    Apr

  • 30

    May

11:36
02/21/18
02/21
11:36
02/21/18
11:36
General news
2-Yr FRN Note Auction Bid/Cover data reported »

2-Yr FRN Note Auction…

11:36
02/21/18
02/21
11:36
02/21/18
11:36
General news
2-Yr FRN Note Auction Total Amount data reported »

2-Yr FRN Note Auction…

PCRX

Pacira

$31.25

1.1 (3.65%)

11:36
02/21/18
02/21
11:36
02/21/18
11:36
Recommendations
Pacira analyst commentary  »

Pacira Q4 sales momentum…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 21

    Feb

  • 06

    Apr

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.